Sort   by:  
 Page size 
ProteomicsLabel-free proteomics to study the effect of IL-9 on MDA-MB-231 and HeLa cells
To study the proteomic profile of HeLa and MDA-MB-231 upon IL-9 stimulation, we treated both the cell-lines with the cytokine for 24 hours. Quantitative label-free proteomic analysis was then performed and abundance ratios were obtained for proteins from cells in IL-9 treated v. untreated conditions...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-03-03 | MSV000086990 | MassIVE
ProteomicsDifferentially expressed proteins in Human Primary Keratinocytes upon IL-9 stimulation
HPKs from 3-5 healthy individual donors were pre-stimulated with TGFb (10ng/ml) plus IL-4 (20ng/ml) to upregulated the IL-9R (Das et al., 2019). Next day, HPKs were stimulated with IL-9 (50ng/ml) or in combination with IFNg (10ng/ml) for 24 hours at 37 degree C with 5% CO2. Sample preparation for L...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-01-28 | MSV000086776 | MassIVE
MetabolomicsSequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID

The post-acute sequelae of COVID-19 (PASC), also known as long COVID, is often associated with debilitating symptoms and adverse multisystem consequences. We obtain plasma samples from 117 individuals during and 6 mth following their acute phase of infection to comprehensively profile and as...

2024-02-23 | MTBLS7337 | MetaboLights
UnknownPRIORI-T: A tool for rare disease gene prioritization using MEDLINE.
Not available
S-EPMC7173875 | biostudies-literature
UnknownSelective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.
Not available
S-EPMC5809307 | biostudies-literature
UnknownReversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
Not available
S-EPMC5963729 | biostudies-literature
UnknownSmall-molecule control of CAR T cells.
Not available
S-EPMC12746335 | biostudies-literature
UnknownEngineered off-the-shelf therapeutic T cells resist host immune rejection.
Not available
S-EPMC7854790 | biostudies-literature
UnknownFeasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
Not available
S-EPMC9840107 | biostudies-literature
UnknownNotch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29.
Not available
S-EPMC6281167 | biostudies-literature
Sort   by:  
 Page size